Physician profile

Rupesh Jain

Plastic Surgery · Colorado Springs, CO

NPI 1598850810

$1,768.33

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$77.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mentor Worldwide LLC $358.36 2019-2024 Mentor Memorygel Resterilizable Gel Sizer
Merz North America, INC. $356.82 2019-2021
Medline Industries LP $266.86 2019
Organogenesis INC. $231.16 2019
Smith+Nephew, INC. $227.37 2019
Apyx Medical Corporation $161.56 2019
Shionogi INC $54.77 2019
Galderma Laboratories, L.P. $46.81 2020-2023
Abbvie INC. $31.67 2023
Sientra, INC. $19.10 2021
Integra Lifesciences Corporation $13.85 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rupesh Jain

$1,768.33

in general payments reported 2019-2025

Years
2019-2024
Top company
Mentor Worldwide LLC

https://glasscript.com/doctor/299601/rupesh-jain

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.